Mr. Pham Trung Kien, Chairman of the Board of Directors of Ladophar, a leading pharmaceutical company in Vietnam, has recently filed to sell over 1.08 million shares of the company's stock, equivalent to 8.1% of its capital. If the transaction is successful, Mr. Kien's ownership will decrease to 0.7%, and he will no longer be a major shareholder. The sale is intended for portfolio restructuring and will be executed through matched orders and/or put-through transactions between August 29 and September 27.